Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Bet On It: Arizona legalizes sports betting, while Maryland nears finish line » 16:03
04/16/21
04/16
16:03
04/16/21
16:03
DKNG

DraftKings

$57.96 /

+0.465 (+0.81%)

, CZR

Caesars

$93.59 /

+0.4 (+0.43%)

, PDYPY

Flutter Entertainment

$109.10 /

+3.03 (+2.86%)

, BALY

Bally's

$58.60 /

+1.1 (+1.91%)

, JKPTF

Gamesys Group

$26.80 /

+0.3 (+1.13%)

, LVS

Las Vegas Sands

$61.09 /

-0.21 (-0.34%)

, ACEL

Accel Entertainment

$11.87 /

+0.18 (+1.54%)

, BYD

Boyd Gaming

$65.85 /

+0.73 (+1.12%)

, CHDN

Churchill Downs

$220.43 /

+3.02 (+1.39%)

, GAN

Gan Limited

$18.29 /

+0.3 (+1.67%)

, MGM

MGM Resorts

$40.25 /

+0.57 (+1.44%)

, PENN

Penn National

$99.86 /

-0.81 (-0.80%)

, SGMS

Scientific Games

$47.37 /

+2.46 (+5.48%)

, SCR

Score Media

$21.05 /

+2.3 (+12.27%)

, WIMHY

William Hill

$15.12 /

+0.14 (+0.93%)

, WYNN

Wynn Resorts

$127.47 /

-0.43 (-0.34%)

, RSI

Rush Street Interactive

$14.39 /

+0.06 (+0.42%)

Welcome to the latest…

ShowHide Related Items >><<
WYNN Wynn Resorts
$127.47 /

-0.43 (-0.34%)

SGMS Scientific Games
$47.37 /

+2.46 (+5.48%)

RSI Rush Street Interactive
$14.39 /

+0.06 (+0.42%)

PENN Penn National
$99.86 /

-0.81 (-0.80%)

PDYPY Flutter Entertainment
$109.10 /

+3.03 (+2.86%)

MGM MGM Resorts
$40.25 /

+0.57 (+1.44%)

LVS Las Vegas Sands
$61.09 /

-0.21 (-0.34%)

JKPTF Gamesys Group
$26.80 /

+0.3 (+1.13%)

GAN Gan Limited
$18.29 /

+0.3 (+1.67%)

DKNG DraftKings
$57.96 /

+0.465 (+0.81%)

CZR Caesars
$93.59 /

+0.4 (+0.43%)

CHDN Churchill Downs
$220.43 /

+3.02 (+1.39%)

BYD Boyd Gaming
$65.85 /

+0.73 (+1.12%)

BALY Bally's
$58.60 /

+1.1 (+1.91%)

ACEL Accel Entertainment
$11.87 /

+0.18 (+1.54%)

DKNG DraftKings
$57.96 /

+0.465 (+0.81%)

04/07/21 Truist
Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud'
04/06/21 Credit Suisse
Reports, contacts point to sports betting momentum in NY, Credit Suisse says
04/01/21 Credit Suisse
NY online sports betting likely to make it into budget, says Credit Suisse
03/30/21 Loop Capital
Loop Capital recommends buying DraftKings going into NY budget deadline
CZR Caesars
$93.59 /

+0.4 (+0.43%)

04/08/21 KeyBanc
Caesars price target raised to $110 from $102 at KeyBanc
04/05/21
Fly Intel: Top five analyst upgrades
PDYPY Flutter Entertainment
$109.10 /

+3.03 (+2.86%)

04/12/21 RBC Capital
Flutter price target raised to 17,000 GBp from 15,700 GBp at RBC Capital
03/30/21 Barclays
Flutter price target raised to 17,500 GBp from 15,000 GBp at Barclays
BALY Bally's
$58.60 /

+1.1 (+1.91%)

04/08/21 KeyBanc
Bally's price target raised to $70 from $65 at KeyBanc
03/29/21 Truist
Early March casino data looks 'very positive,' says Truist
03/25/21 Stifel
Bally's price target raised to $75 from $70 at Stifel
03/24/21 Jefferies
Gamesys Group and Bally's an 'interesting combination,' says Jefferies
JKPTF Gamesys Group
$26.80 /

+0.3 (+1.13%)

04/14/21 Canaccord
Gamesys Group downgraded to Hold on merger at Canaccord
04/14/21 Canaccord
Gamesys Group downgraded to Hold from Buy at Canaccord
03/16/21 Jefferies
Gamesys Group price target raised to 2,150 GBp from 1,930 GBp at Jefferies
LVS Las Vegas Sands
$61.09 /

-0.21 (-0.34%)

03/29/21 Deutsche Bank
New York may be 'kicking the can' on sports betting, says Deutsche
03/18/21 JPMorgan
Micro-betting market in U.S. 'could be substantial,' says JPMorgan
ACEL Accel Entertainment
$11.87 /

+0.18 (+1.54%)

04/08/21 JPMorgan
Accel Entertainment initiated with an Overweight at JPMorgan
03/16/21 Deutsche Bank
Accel Entertainment price target raised to $13 from $12 at Deutsche Bank
03/08/21 Macquarie
Accel Entertainment initiated with a Neutral at Macquarie
03/08/21 Macquarie
Accel Entertainment initiated with a Neutral at Macquarie
BYD Boyd Gaming
$65.85 /

+0.73 (+1.12%)

04/16/21 Deutsche Bank
Boyd Gaming price target raised to $71 from $67 at Deutsche Bank
04/08/21 KeyBanc
Boyd Gaming price target raised to $69 from $61 at KeyBanc
04/05/21 Morgan Stanley
Caesars upgraded to Overweight from Equal Weight at Morgan Stanley
CHDN Churchill Downs
$220.43 /

+3.02 (+1.39%)

03/01/21 KeyBanc
Churchill Downs price target raised to $250 from $239 at KeyBanc
02/09/21 Morgan Stanley
Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds
GAN Gan Limited
$18.29 /

+0.3 (+1.67%)

03/26/21
Fly Intel: Top five analyst downgrades
03/26/21 Craig-Hallum
Gan Limited downgraded to Hold from Buy at Craig-Hallum
MGM MGM Resorts
$40.25 /

+0.57 (+1.44%)

04/05/21 Morgan Stanley
Morgan Stanley upgrades MGM Resorts to Overweight after Vegas visit
PENN Penn National
$99.86 /

-0.81 (-0.80%)

SGMS Scientific Games
$47.37 /

+2.46 (+5.48%)

03/04/21 Credit Suisse
Scientific Games price target raised to $35 from $9 at Credit Suisse
02/09/21 Craig-Hallum
Scientific Games Digital segment still 'underappreciated,' says Craig-Hallum
01/19/21 Jefferies
Scientific Games price target raised to $55 from $50 at Jefferies
01/14/21 Truist
Scientific Games price target raised to $60 from $45 at Truist
SCR Score Media
$21.05 /

+2.3 (+12.27%)

03/23/21 Credit Suisse
Score Media initiated with an Outperform at Credit Suisse
03/22/21 Macquarie
Score Media initiated with an Outperform at Macquarie
WIMHY William Hill
$15.12 /

+0.14 (+0.93%)

WYNN Wynn Resorts
$127.47 /

-0.43 (-0.34%)

04/06/21
Fly Intel: Top five analyst upgrades
04/06/21 Argus
Wynn Resorts upgraded to Buy from Hold at Argus
RSI Rush Street Interactive
$14.39 /

+0.06 (+0.42%)

04/16/21
Fly Intel: Top five analyst initiations
04/16/21 Jefferies
Jefferies starts Rush Street Interactive at Buy with $21 price target
04/16/21 Jefferies
Rush Street Interactive initiated with a Buy at Jefferies
WYNN Wynn Resorts
$127.47 /

-0.43 (-0.34%)

SGMS Scientific Games
$47.37 /

+2.46 (+5.48%)

RSI Rush Street Interactive
$14.39 /

+0.06 (+0.42%)

PENN Penn National
$99.86 /

-0.81 (-0.80%)

MGM MGM Resorts
$40.25 /

+0.57 (+1.44%)

LVS Las Vegas Sands
$61.09 /

-0.21 (-0.34%)

GAN Gan Limited
$18.29 /

+0.3 (+1.67%)

DKNG DraftKings
$57.96 /

+0.465 (+0.81%)

CZR Caesars
$93.59 /

+0.4 (+0.43%)

CHDN Churchill Downs
$220.43 /

+3.02 (+1.39%)

BYD Boyd Gaming
$65.85 /

+0.73 (+1.12%)

BALY Bally's
$58.60 /

+1.1 (+1.91%)

ACEL Accel Entertainment
$11.87 /

+0.18 (+1.54%)

  • 16
    Apr
  • 25
    Feb
  • 09
    Feb
  • 17
    Dec
  • 07
    Oct
  • 29
    Sep
  • 25
    Sep
  • 24
    Sep
  • 19
    Jun
  • 12
    May
  • 05
    May
WYNN Wynn Resorts
$127.47 /

-0.43 (-0.34%)

SCR Score Media
$21.05 /

+2.3 (+12.27%)

PDYPY Flutter Entertainment
$109.10 /

+3.03 (+2.86%)

LVS Las Vegas Sands
$61.09 /

-0.21 (-0.34%)

DKNG DraftKings
$57.96 /

+0.465 (+0.81%)

CZR Caesars
$93.59 /

+0.4 (+0.43%)

BYD Boyd Gaming
$65.85 /

+0.73 (+1.12%)

BALY Bally's
$58.60 /

+1.1 (+1.91%)

WYNN Wynn Resorts
$127.47 /

-0.43 (-0.34%)

LVS Las Vegas Sands
$61.09 /

-0.21 (-0.34%)

JKPTF Gamesys Group
$26.80 /

+0.3 (+1.13%)

GAN Gan Limited
$18.29 /

+0.3 (+1.67%)

DKNG DraftKings
$57.96 /

+0.465 (+0.81%)

CZR Caesars
$93.59 /

+0.4 (+0.43%)

BYD Boyd Gaming
$65.85 /

+0.73 (+1.12%)

BALY Bally's
$58.60 /

+1.1 (+1.91%)

WYNN Wynn Resorts
$127.47 /

-0.43 (-0.34%)

SGMS Scientific Games
$47.37 /

+2.46 (+5.48%)

SCR Score Media
$21.05 /

+2.3 (+12.27%)

RSI Rush Street Interactive
$14.39 /

+0.06 (+0.42%)

PENN Penn National
$99.86 /

-0.81 (-0.80%)

MGM MGM Resorts
$40.25 /

+0.57 (+1.44%)

LVS Las Vegas Sands
$61.09 /

-0.21 (-0.34%)

GAN Gan Limited
$18.29 /

+0.3 (+1.67%)

DKNG DraftKings
$57.96 /

+0.465 (+0.81%)

CZR Caesars
$93.59 /

+0.4 (+0.43%)

BYD Boyd Gaming
$65.85 /

+0.73 (+1.12%)

Periodicals
Airbnb CEO tells CNBC company will need millions more hosts to meet demand » 12:22
04/16/21
04/16
12:22
04/16/21
12:22
ABNB

Airbnb

$176.85 /

+1.63 (+0.93%)

Airbnb CEO Brian Chesky…

Airbnb CEO Brian Chesky told CNBC that the company will need to add millions of new hosts to accommodate guests as travel picks up as the COVID-19 pandemic begins to subside. "To meet the demand over the coming years, we're going to need millions more hosts," Chesky said on CNBC's "TechCheck." "I think that we probably will have a high cost problem where there will probably be more guests coming to Airbnb than we'll have hosts for, because ... we think there's going to be a travel rebound coming that's unlike anything we've ever seen," the CEO added. "We are working our hardest to get more hosts on the platform." Reference Link

ShowHide Related Items >><<
ABNB Airbnb
$176.85 /

+1.63 (+0.93%)

ABNB Airbnb
$176.85 /

+1.63 (+0.93%)

04/05/21 Evercore ISI
Airbnb initiated with an Outperform at Evercore ISI
03/31/21 Wolfe Research
Airbnb assumed with a Peer Perform at Wolfe Research
03/10/21 Citi
Airbnb resumed with a Neutral at Citi
03/03/21 Truist
Airbnb price target raised to $180 from $154 at Truist
ABNB Airbnb
$176.85 /

+1.63 (+0.93%)

  • 10
    Dec
ABNB Airbnb
$176.85 /

+1.63 (+0.93%)

ABNB Airbnb
$176.85 /

+1.63 (+0.93%)

ABNB Airbnb
$176.85 /

+1.63 (+0.93%)

Options
Farfetch Limited call volume above normal and directionally bullish » 11:45
04/16/21
04/16
11:45
04/16/21
11:45
FTCH

Farfetch

$50.25 /

-0.84 (-1.64%)

Bullish option flow…

Bullish option flow detected in Farfetch Limited with 4,334 calls trading, 1.6x expected, and implied vol increasing over 1 point to 74.38%. May-21 60 calls and Apr-21 48 puts are the most active options, with total volume in those strikes near 4,600 contracts. The Put/Call Ratio is 0.43. Earnings are expected on May 13th.

ShowHide Related Items >><<
FTCH Farfetch
$50.25 /

-0.84 (-1.64%)

FTCH Farfetch
$50.25 /

-0.84 (-1.64%)

04/08/21 JPMorgan
Farfetch 31% pullback brings 'compelling buying opportunity,' says JPMorgan
02/23/21 Credit Suisse
Farfetch price target raised to $85 from $53 at Credit Suisse
12/22/20 Wells Fargo
Farfetch price target raised to $60 from $50 at Wells Fargo
12/08/20 JPMorgan
Farfetch price target raised to $68 from $62 at JPMorgan
FTCH Farfetch
$50.25 /

-0.84 (-1.64%)

  • 06
    Apr
FTCH Farfetch
$50.25 /

-0.84 (-1.64%)

FTCH Farfetch
$50.25 /

-0.84 (-1.64%)

FTCH Farfetch
$50.25 /

-0.84 (-1.64%)

Initiation
Fly Intel: Top five analyst initiations » 09:55
04/16/21
04/16
09:55
04/16/21
09:55
APLS

Apellis

$46.16 /

+1.39 (+3.10%)

, DRNA

Dicerna

$29.17 /

+0.6 (+2.10%)

, EDIT

Editas Medicine

$37.35 /

-3.56 (-8.70%)

, PLMR

Palomar

$73.23 /

-0.585 (-0.79%)

, RSI

Rush Street Interactive

$14.86 /

+0.53 (+3.70%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Apellis (APLS) initiated with a Buy at Goldman Sachs. 2. Dicerna (DRNA) initiated with a Buy at Goldman Sachs. 3. Editas Medicine (EDIT) initiated with a Sell at Goldman Sachs. 4. Palomar (PLMR) assumed with an Overweight at JPMorgan. 5. Rush Street Interactive (RSI) initiated with a Buy at Jefferies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
RSI Rush Street Interactive
$14.86 /

+0.53 (+3.70%)

PLMR Palomar
$73.23 /

-0.585 (-0.79%)

EDIT Editas Medicine
$37.35 /

-3.56 (-8.70%)

DRNA Dicerna
$29.17 /

+0.6 (+2.10%)

APLS Apellis
$46.16 /

+1.39 (+3.10%)

APLS Apellis
$46.16 /

+1.39 (+3.10%)

04/16/21 Goldman Sachs
Apellis initiated with a Buy at Goldman Sachs
04/14/21 Citi
Apellis year-to-date selloff brings 'very good entry point,' says Citi
03/29/21 JPMorgan
Apellis added to Analyst Focus List with $87 target at JPMorgan
01/29/21 Baird
Apellis assumed at Outperform at Baird
DRNA Dicerna
$29.17 /

+0.6 (+2.10%)

04/16/21 Goldman Sachs
Dicerna initiated with a Buy at Goldman Sachs
03/18/21
Dicerna to hold a webinar on DCR-AUD disorder
03/02/21 H.C. Wainwright
Dicerna price target raised to $40 from $35 at H.C. Wainwright
EDIT Editas Medicine
$37.35 /

-3.56 (-8.70%)

04/16/21 Goldman Sachs
Editas Medicine initiated with a Sell at Goldman Sachs
03/22/21 Credit Suisse
Editas Medicine initiated with an Outperform at Credit Suisse
03/17/21 Guggenheim
Editas Medicine assumed with a Neutral at Guggenheim
03/01/21 Barclays
Editas Medicine downgraded to Equal Weight from Overweight at Barclays
PLMR Palomar
$73.23 /

-0.585 (-0.79%)

04/16/21 JMP Securities
Palomar price target lowered to $95 from $105 at JMP Securities
04/16/21 JPMorgan
Palomar assumed with an Overweight at JPMorgan
03/26/21
Fly Intel: Top five analyst upgrades
03/26/21 Barclays
Palomar upgraded to Overweight from Equal Weight at Barclays
RSI Rush Street Interactive
$14.86 /

+0.53 (+3.70%)

04/16/21 Jefferies
Jefferies starts Rush Street Interactive at Buy with $21 price target
04/16/21 Jefferies
Rush Street Interactive initiated with a Buy at Jefferies
04/01/21 Credit Suisse
NY online sports betting likely to make it into budget, says Credit Suisse
03/23/21 Goldman Sachs
Rush Street Interactive price target raised to $25 from $23 at Goldman Sachs
RSI Rush Street Interactive
$14.86 /

+0.53 (+3.70%)

PLMR Palomar
$73.23 /

-0.585 (-0.79%)

EDIT Editas Medicine
$37.35 /

-3.56 (-8.70%)

DRNA Dicerna
$29.17 /

+0.6 (+2.10%)

APLS Apellis
$46.16 /

+1.39 (+3.10%)

  • 21
    Jan
  • 24
    Jun
  • 24
    Jun
RSI Rush Street Interactive
$14.86 /

+0.53 (+3.70%)

RSI Rush Street Interactive
$14.86 /

+0.53 (+3.70%)

PLMR Palomar
$73.23 /

-0.585 (-0.79%)

EDIT Editas Medicine
$37.35 /

-3.56 (-8.70%)

DRNA Dicerna
$29.17 /

+0.6 (+2.10%)

APLS Apellis
$46.16 /

+1.39 (+3.10%)

RSI Rush Street Interactive
$14.86 /

+0.53 (+3.70%)

EDIT Editas Medicine
$37.35 /

-3.56 (-8.70%)

On The Fly
Fly Intel: Pre-market Movers » 08:58
04/16/21
04/16
08:58
04/16/21
08:58
STT

State Street

$86.53 /

-0.13 (-0.15%)

, ALXN

Alexion

$157.53 /

+2.25 (+1.45%)

, DRNA

Dicerna

$28.54 /

+0.73 (+2.62%)

, EBET

Esports Technologies

$36.05 /

+12.95 (+56.06%)

, CFG

Citizens Financial

$44.66 /

-0.845 (-1.86%)

, ALLY

Ally Financial

$47.65 /

-0.105 (-0.22%)

, PPG

PPG

$153.99 /

+3.17 (+2.10%)

, MS

Morgan Stanley

$80.89 /

+0.11 (+0.14%)

, BK

BNY Mellon

$48.02 /

-0.6 (-1.23%)

, EDIT

Editas Medicine

$41.02 /

-0.5 (-1.20%)

, AZN

AstraZeneca

$50.84 /

+0.97 (+1.95%)

Check out this morning's…

ShowHide Related Items >><<
STT State Street
$86.53 /

-0.13 (-0.15%)

PPG PPG
$153.99 /

+3.17 (+2.10%)

MS Morgan Stanley
$80.89 /

+0.11 (+0.14%)

EDIT Editas Medicine
$41.02 /

-0.5 (-1.20%)

DRNA Dicerna
$28.54 /

+0.73 (+2.62%)

CFG Citizens Financial
$44.66 /

-0.845 (-1.86%)

BK BNY Mellon
$48.02 /

-0.6 (-1.23%)

AZN AstraZeneca
$50.84 /

+0.97 (+1.95%)

ALXN Alexion
$157.53 /

+2.25 (+1.45%)

ALLY Ally Financial
$47.65 /

-0.105 (-0.22%)

STT State Street
$86.53 /

-0.13 (-0.15%)

04/09/21 Deutsche Bank
State Street price target raised to $100 from $97 at Deutsche Bank
04/07/21 Barclays
State Street price target raised to $104 from $99 at Barclays
04/01/21 Wells Fargo
State Street price target raised to $90 from $83 at Wells Fargo
04/01/21 Morgan Stanley
State Street price target raised to $103 from $102 at Morgan Stanley
ALXN Alexion
$157.53 /

+2.25 (+1.45%)

03/23/21
Fly Intel: Top five analyst downgrades
03/23/21 SVB Leerink
SVB Leerink moving to sidelines on Alexion, five others on industry concerns
03/23/21 SVB Leerink
Alexion downgraded to Market Perform from Outperform at SVB Leerink
02/04/21 Piper Sandler
Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
DRNA Dicerna
$28.54 /

+0.73 (+2.62%)

04/16/21 Goldman Sachs
Dicerna initiated with a Buy at Goldman Sachs
03/18/21
Dicerna to hold a webinar on DCR-AUD disorder
03/02/21 H.C. Wainwright
Dicerna price target raised to $40 from $35 at H.C. Wainwright
EBET Esports Technologies
$36.05 /

+12.95 (+56.06%)

CFG Citizens Financial
$44.66 /

-0.845 (-1.86%)

04/09/21 Jefferies
Citizens Financial price target raised to $47 from $42 at Jefferies
04/07/21 Barclays
Citizens Financial price target raised to $54 from $49 at Barclays
04/01/21 Deutsche Bank
Citizens Financial price target raised to $50 from $44 at Deutsche Bank
03/30/21 Stephens
Citizens Financial price target raised to $54 from $45 at Stephens
ALLY Ally Financial
$47.65 /

-0.105 (-0.22%)

04/15/21 JPMorgan
Ally Financial price target raised to $54 from $48 at JPMorgan
04/13/21 Wells Fargo
Ally Financial price target raised to $57 from $51 at Wells Fargo
04/12/21 BofA
Ally Financial reinstated with a Buy at BofA
04/08/21 Evercore ISI
Ally Financial initiated with an Outperform at Evercore ISI
PPG PPG
$153.99 /

+3.17 (+2.10%)

04/15/21 Citi
Citi opens '30-day negative catalyst watch' on Axalta, PPG
04/07/21 Wells Fargo
PPG price target raised to $173 from $165 at Wells Fargo
03/15/21 Credit Suisse
PPG assumed with a Neutral at Credit Suisse
01/26/21 BofA
PPG upgraded to Buy from Neutral at BofA
MS Morgan Stanley
$80.89 /

+0.11 (+0.14%)

04/09/21 JMP Securities
Goldman Sachs price target raised to $400 from $338 at JMP Securities
04/07/21 Barclays
Morgan Stanley price target raised to $98 from $95 at Barclays
04/01/21 Deutsche Bank
Morgan Stanley price target raised to $79 from $68 at Deutsche Bank
04/01/21 UBS
Morgan Stanley price target raised to $92 from $84 at UBS
BK BNY Mellon
$48.02 /

-0.6 (-1.23%)

04/09/21 Deutsche Bank
BNY Mellon price target raised to $54 from $50 at Deutsche Bank
04/07/21 Barclays
BNY Mellon price target raised to $57 from $55 at Barclays
03/26/21 JPMorgan
JPMorgan sees BNY Mellon, Wells Fargo among banks with most buyback capacity
03/24/21
Fly Intel: Top five analyst upgrades
EDIT Editas Medicine
$41.02 /

-0.5 (-1.20%)

04/16/21 Goldman Sachs
Editas Medicine initiated with a Sell at Goldman Sachs
03/22/21 Credit Suisse
Editas Medicine initiated with an Outperform at Credit Suisse
03/17/21 Guggenheim
Editas Medicine assumed with a Neutral at Guggenheim
03/01/21 Barclays
Editas Medicine downgraded to Equal Weight from Overweight at Barclays
AZN AstraZeneca
$50.84 /

+0.97 (+1.95%)

04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
04/12/21 Argus
AstraZeneca downgraded to Hold from Buy at Argus
STT State Street
$86.53 /

-0.13 (-0.15%)

PPG PPG
$153.99 /

+3.17 (+2.10%)

MS Morgan Stanley
$80.89 /

+0.11 (+0.14%)

EDIT Editas Medicine
$41.02 /

-0.5 (-1.20%)

DRNA Dicerna
$28.54 /

+0.73 (+2.62%)

CFG Citizens Financial
$44.66 /

-0.845 (-1.86%)

BK BNY Mellon
$48.02 /

-0.6 (-1.23%)

AZN AstraZeneca
$50.84 /

+0.97 (+1.95%)

ALXN Alexion
$157.53 /

+2.25 (+1.45%)

ALLY Ally Financial
$47.65 /

-0.105 (-0.22%)

  • 15
    Apr
  • 21
    Jan
  • 24
    Jun
STT State Street
$86.53 /

-0.13 (-0.15%)

MS Morgan Stanley
$80.89 /

+0.11 (+0.14%)

CFG Citizens Financial
$44.66 /

-0.845 (-1.86%)

BK BNY Mellon
$48.02 /

-0.6 (-1.23%)

AZN AstraZeneca
$50.84 /

+0.97 (+1.95%)

STT State Street
$86.53 /

-0.13 (-0.15%)

PPG PPG
$153.99 /

+3.17 (+2.10%)

MS Morgan Stanley
$80.89 /

+0.11 (+0.14%)

EDIT Editas Medicine
$41.02 /

-0.5 (-1.20%)

DRNA Dicerna
$28.54 /

+0.73 (+2.62%)

BK BNY Mellon
$48.02 /

-0.6 (-1.23%)

AZN AstraZeneca
$50.84 /

+0.97 (+1.95%)

ALXN Alexion
$157.53 /

+2.25 (+1.45%)

ALLY Ally Financial
$47.65 /

-0.105 (-0.22%)

PPG PPG
$153.99 /

+3.17 (+2.10%)

MS Morgan Stanley
$80.89 /

+0.11 (+0.14%)

EDIT Editas Medicine
$41.02 /

-0.5 (-1.20%)

CFG Citizens Financial
$44.66 /

-0.845 (-1.86%)

AZN AstraZeneca
$50.84 /

+0.97 (+1.95%)

ALXN Alexion
$157.53 /

+2.25 (+1.45%)

ALLY Ally Financial
$47.65 /

-0.105 (-0.22%)

Recommendations
Zscaler acquisition adds to cloud protection portfolio, says Canaccord » 07:24
04/16/21
04/16
07:24
04/16/21
07:24
ZS

Zscaler

/

+

Canaccord analyst T.…

Canaccord analyst T. Michael Walkley noted Zscaler added to its cloud protection portfolio with its strategic acquisition of Trustdome. The analyst believes its further substantiates his positive thesis on the company's ability to securely facilitate customers' cloud adoption initiatives, and believes Zscaler is a core centerpiece of a robust security framework. Walkley reiterated his Buy rating and $250 price target on Zscaler shares.

ShowHide Related Items >><<
ZS Zscaler
/

+

ZS Zscaler
/

+

04/12/21 Mizuho
Zscaler initiated with a Buy at Mizuho
03/24/21
Fly Intel: Top five analyst upgrades
03/23/21 Truist
Truist upgrades Zscaler to Buy, sees 'large deals' driving upside
03/23/21 Truist
Zscaler upgraded to Buy from Hold at Truist
ZS Zscaler
/

+

ZS Zscaler
/

+

ZS Zscaler
/

+

Conference/Events
American College of Medical Genetics & Genomics » 04:55
04/16/21
04/16
04:55
04/16/21
04:55
APLT

Applied Therapeutics

$16.73 /

+0.16 (+0.97%)

, BNGO

Bionano Genomics

$6.12 /

-0.305 (-4.75%)

, CNTG

Centogene

$11.67 /

-0.73 (-5.89%)

, DGX

Quest Diagnostics

$129.23 /

+2.03 (+1.60%)

, FIXX

Homology Medicines

$7.03 /

-0.19 (-2.63%)

, FOLD

Amicus

$10.33 /

+0.345 (+3.46%)

, ILMN

Illumina

$401.83 /

+4.65 (+1.17%)

, NTRA

Natera

$106.24 /

+4.81 (+4.74%)

, NVTA

Invitae

$39.08 /

+ (+0.00%)

, RARE

Ultragenyx

$109.71 /

+1.59 (+1.47%)

, SNY

Sanofi

$50.68 /

+0.4199 (+0.84%)

, TAK

Takeda Pharmaceutical

$17.21 /

+0.155 (+0.91%)

, UA

Under Armour

$18.32 /

-0.115 (-0.62%)

, XFOR

X4 Pharmaceuticals

$8.77 /

-0.21 (-2.34%)

Annual Clinical Genetics…

Annual Clinical Genetics Virtual Meeting of ACMG to be held on April 13-16. Webcast Link

ShowHide Related Items >><<
XFOR X4 Pharmaceuticals
$8.77 /

-0.21 (-2.34%)

UA Under Armour
$18.32 /

-0.115 (-0.62%)

TAK Takeda Pharmaceutical
$17.21 /

+0.155 (+0.91%)

SNY Sanofi
$50.68 /

+0.4199 (+0.84%)

RARE Ultragenyx
$109.71 /

+1.59 (+1.47%)

NVTA Invitae
$39.08 /

+ (+0.00%)

NTRA Natera
$106.24 /

+4.81 (+4.74%)

ILMN Illumina
$401.83 /

+4.65 (+1.17%)

FOLD Amicus
$10.33 /

+0.345 (+3.46%)

FIXX Homology Medicines
$7.03 /

-0.19 (-2.63%)

DGX Quest Diagnostics
$129.23 /

+2.03 (+1.60%)

CNTG Centogene
$11.67 /

-0.73 (-5.89%)

BNGO Bionano Genomics
$6.12 /

-0.305 (-4.75%)

APLT Applied Therapeutics
$16.73 /

+0.16 (+0.97%)

APLT Applied Therapeutics
$16.73 /

+0.16 (+0.97%)

11/17/20 Barclays
Applied Therapeutics price target lowered to $44 from $64 at Barclays
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
04/22/20
Fly Intel: Top five analyst initiations
BNGO Bionano Genomics
$6.12 /

-0.305 (-4.75%)

02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
12/04/20 Roth Capital
Bionano Genomics downgraded to Neutral from Buy at Roth Capital
CNTG Centogene
$11.67 /

-0.73 (-5.89%)

11/05/20 Credit Suisse
Centogene initiated with an Outperform at Credit Suisse
04/24/20 BTIG
Centogene price target raised to $23 from $18 at BTIG
04/24/20 Evercore ISI
Centogene downgraded to In Line from Outperform at Evercore ISI
DGX Quest Diagnostics
$129.23 /

+2.03 (+1.60%)

03/12/21 Baird
Quest Diagnostics downgraded to Neutral from Outperform at Baird
01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
FIXX Homology Medicines
$7.03 /

-0.19 (-2.63%)

03/01/21 Stifel
Homology Medicines initiated with a Hold at Stifel
03/01/21 Oppenheimer
Homology Medicines loses potential source of upside, says Oppenheimer
12/14/20 H.C. Wainwright
Homology Medicines transferred with Buy, $30 target at H.C. Wainwright
11/08/20 Oppenheimer
Homology Medicines selloff unjustified in wake of clinical PoC, says Oppenheimer
FOLD Amicus
$10.33 /

+0.345 (+3.46%)

04/14/21 Cantor Fitzgerald
Amicus upgraded to Overweight from Neutral at Cantor Fitzgerald
04/13/21 Cantor Fitzgerald
Amicus upgraded to Overweight from Neutral at Cantor Fitzgerald
03/01/21 Stifel
Amicus initiated with a Hold at Stifel
02/12/21
Fly Intel: Top five analyst downgrades
ILMN Illumina
$401.83 /

+4.65 (+1.17%)

04/06/21 Wells Fargo
Illumina price target raised to $330 from $300 at Wells Fargo
04/06/21 Canaccord
Illumina price target raised to $460 from $445 at Canaccord
04/05/21 Evercore ISI
Evercore upgrades Edwards to Outperform ahead of its 'best pipeline cycle'
03/31/21 Canaccord
Canaccord upgrades Illumina, says worth owning with or without Grail
NTRA Natera
$106.24 /

+4.81 (+4.74%)

03/10/21 Piper Sandler
Natera, Genentech start Phase 3 trial using Signatera, says Piper Sandler
02/26/21 Piper Sandler
Natera price target raised to $150 from $127 at Piper Sandler
01/27/21 Truist
Natera initiated with a Buy at Truist
01/19/21 BTIG
Natera price target raised to $135 from $112 at BTIG
NVTA Invitae
$39.08 /

+ (+0.00%)

04/05/21 Oppenheimer
Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock
04/05/21 Oppenheimer
Invitae upgraded to Outperform from Perform at Oppenheimer
02/18/21 Ladenburg
Invitae upgraded to Buy with $58 price target at Ladenburg
02/18/21 Ladenburg
Invitae upgraded to Buy from Neutral at Ladenburg
RARE Ultragenyx
$109.71 /

+1.59 (+1.47%)

03/24/21 Stifel
Stifel remains optimistic on GTX-102 and Ultragenyx ahead of 'important' update
03/01/21 Stifel
Ultragenyx resumed with a Buy at Stifel
02/12/21 Wedbush
Ultragenyx price target raised to $130 from $113 at Wedbush
02/12/21 Barclays
Ultragenyx price target raised to $186 from $176 at Barclays
SNY Sanofi
$50.68 /

+0.4199 (+0.84%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
TAK Takeda Pharmaceutical
$17.21 /

+0.155 (+0.91%)

04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
04/05/21 Barclays
Molecular Templates MT-3724 discontinuation shouldn't be surprise, says Barclays
04/05/21 Jefferies
Takeda Pharmaceutical downgraded to Hold from Buy at Jefferies
UA Under Armour
$18.32 /

-0.115 (-0.62%)

02/22/21 Williams Capital
Under Armour initiated with a Hold at Williams Trading
02/19/21 Oppenheimer
Opco upgrades Under Armour on potential return to 'outsized' sales growth
02/19/21 Oppenheimer
Under Armour upgraded to Outperform from Perform at Oppenheimer
02/11/21 Jefferies
Under Armour price target raised to $30 from $25 at Jefferies
XFOR X4 Pharmaceuticals
$8.77 /

-0.21 (-2.34%)

12/17/20 Brookline
X4 Pharmaceuticals initiated with a Buy at Brookline
12/14/20 Roth Capital
New CMO 'another solid addition' to X4 Pharmaceuticals team, says Roth Capital
06/12/20 Roth Capital
X4 Pharmaceuticals data boost confidence in Phase 3 study, says Roth Capital
XFOR X4 Pharmaceuticals
$8.77 /

-0.21 (-2.34%)

UA Under Armour
$18.32 /

-0.115 (-0.62%)

TAK Takeda Pharmaceutical
$17.21 /

+0.155 (+0.91%)

SNY Sanofi
$50.68 /

+0.4199 (+0.84%)

RARE Ultragenyx
$109.71 /

+1.59 (+1.47%)

NVTA Invitae
$39.08 /

+ (+0.00%)

NTRA Natera
$106.24 /

+4.81 (+4.74%)

ILMN Illumina
$401.83 /

+4.65 (+1.17%)

FOLD Amicus
$10.33 /

+0.345 (+3.46%)

FIXX Homology Medicines
$7.03 /

-0.19 (-2.63%)

DGX Quest Diagnostics
$129.23 /

+2.03 (+1.60%)

CNTG Centogene
$11.67 /

-0.73 (-5.89%)

BNGO Bionano Genomics
$6.12 /

-0.305 (-4.75%)

APLT Applied Therapeutics
$16.73 /

+0.16 (+0.97%)

  • 07
    Apr
  • 12
    Feb
  • 22
    Jan
  • 20
    Jan
  • 08
    Jan
  • 29
    Oct
  • 11
    Sep
  • 10
    Jul
UA Under Armour
$18.32 /

-0.115 (-0.62%)

SNY Sanofi
$50.68 /

+0.4199 (+0.84%)

ILMN Illumina
$401.83 /

+4.65 (+1.17%)

FOLD Amicus
$10.33 /

+0.345 (+3.46%)

UA Under Armour
$18.32 /

-0.115 (-0.62%)

TAK Takeda Pharmaceutical
$17.21 /

+0.155 (+0.91%)

SNY Sanofi
$50.68 /

+0.4199 (+0.84%)

NVTA Invitae
$39.08 /

+ (+0.00%)

NTRA Natera
$106.24 /

+4.81 (+4.74%)

ILMN Illumina
$401.83 /

+4.65 (+1.17%)

FOLD Amicus
$10.33 /

+0.345 (+3.46%)

FIXX Homology Medicines
$7.03 /

-0.19 (-2.63%)

DGX Quest Diagnostics
$129.23 /

+2.03 (+1.60%)

BNGO Bionano Genomics
$6.12 /

-0.305 (-4.75%)

APLT Applied Therapeutics
$16.73 /

+0.16 (+0.97%)

UA Under Armour
$18.32 /

-0.115 (-0.62%)

TAK Takeda Pharmaceutical
$17.21 /

+0.155 (+0.91%)

NVTA Invitae
$39.08 /

+ (+0.00%)

ILMN Illumina
$401.83 /

+4.65 (+1.17%)

FOLD Amicus
$10.33 /

+0.345 (+3.46%)

DGX Quest Diagnostics
$129.23 /

+2.03 (+1.60%)

BNGO Bionano Genomics
$6.12 /

-0.305 (-4.75%)

Initiation
Dicerna initiated with a Buy at Goldman Sachs » 04:53
04/16/21
04/16
04:53
04/16/21
04:53
DRNA

Dicerna

$28.54 /

+0.73 (+2.62%)

Goldman Sachs analyst…

Goldman Sachs analyst Madhu Kumar initiated coverage of Dicerna with a Buy rating and $48 price target, implying 73% upside potential. Relative to pre-commercial RNAi therapeutics peers, Dicerna is undervalued given its "broad" clinical pipeline, "validating" partnerships, and mid-2021 pivotal readout for lactate dehydrogenase A RNAi drug nedosiran in the Phase 3 PHYOX2 trial in primary hyperoxaluria as a "potential inflection point," Kumar tells investors in a research note.

ShowHide Related Items >><<
DRNA Dicerna
$28.54 /

+0.73 (+2.62%)

DRNA Dicerna
$28.54 /

+0.73 (+2.62%)

03/18/21
Dicerna to hold a webinar on DCR-AUD disorder
03/02/21 H.C. Wainwright
Dicerna price target raised to $40 from $35 at H.C. Wainwright
03/02/21 Chardan
Dicerna price target raised to $34 from $25 at Chardan
DRNA Dicerna
$28.54 /

+0.73 (+2.62%)

DRNA Dicerna
$28.54 /

+0.73 (+2.62%)

Thursday
On The Fly
Fly Intel: Wall Street's top stories for Thursday » 16:33
04/15/21
04/15
16:33
04/15/21
16:33
DELL

Dell Technologies

$98.90 /

+6.2 (+6.69%)

, VMW

VMware

$160.06 /

+4.57 (+2.94%)

, C

Citi

$72.53 /

-0.39 (-0.53%)

, BAC

Bank of America

$38.75 /

-1.15 (-2.88%)

, BLK

BlackRock

$818.24 /

+15.52 (+1.93%)

, UNH

UnitedHealth

$390.14 /

+14.39 (+3.83%)

, PEP

PepsiCo

$142.20 /

+ (+0.00%)

, DAL

Delta Air Lines

$46.83 /

-1.32 (-2.74%)

, TMO

Thermo Fisher

$494.70 /

+16.97 (+3.55%)

, PPD

PPD

$45.80 /

+3.3 (+7.76%)

, MRK

Merck

$76.67 /

+0.27 (+0.35%)

, PFE

Pfizer

$37.61 /

+0.45 (+1.21%)

, DNZ

D and Z Media Acquisition

$9.95 /

+0.045 (+0.45%)

, ICE

IntercontinentalExchange

$119.87 /

+1.695 (+1.43%)

, WRI

Weingarten Realty

$30.75 /

+3.375 (+12.33%)

, KIM

Kimco Realty

$19.92 /

+0.445 (+2.28%)

, WIT

Wipro

$6.55 /

+0.445 (+7.29%)

, SPCE

Virgin Galactic

$23.05 /

-3.6 (-13.51%)

, QS

QuantumScape

$35.86 /

-5.02 (-12.28%)

Stocks rose to record…

ShowHide Related Items >><<
WRI Weingarten Realty
$30.75 /

+3.375 (+12.33%)

WIT Wipro
$6.55 /

+0.445 (+7.29%)

UNH UnitedHealth
$390.14 /

+14.39 (+3.83%)

TMO Thermo Fisher
$494.70 /

+16.97 (+3.55%)

SPCE Virgin Galactic
$23.05 /

-3.6 (-13.51%)

QS QuantumScape
$35.86 /

-5.02 (-12.28%)

PPD PPD
$45.80 /

+3.3 (+7.76%)

PFE Pfizer
$37.61 /

+0.45 (+1.21%)

PEP PepsiCo
$142.20 /

+ (+0.00%)

MRK Merck
$76.67 /

+0.27 (+0.35%)

KIM Kimco Realty
$19.92 /

+0.445 (+2.28%)

ICE IntercontinentalExchange
$119.87 /

+1.695 (+1.43%)

DELL Dell Technologies
$98.90 /

+6.2 (+6.69%)

DAL Delta Air Lines
$46.83 /

-1.32 (-2.74%)

C Citi
$72.53 /

-0.39 (-0.53%)

BLK BlackRock
$818.24 /

+15.52 (+1.93%)

BAC Bank of America
$38.75 /

-1.15 (-2.88%)

DELL Dell Technologies
$98.90 /

+6.2 (+6.69%)

04/15/21 UBS
Dell Technologies price target raised to $110 from $90 at UBS
04/15/21 Evercore ISI
Dell Technologies price target raised to $110 from $105 at Evercore ISI
04/15/21 Wells Fargo
Dell Technologies price target raised to $120 from $90 at Wells Fargo
04/15/21 Northland
VMware downgraded to Market Perform from Outperform at Northland
VMW VMware
$160.06 /

+4.57 (+2.94%)

04/15/21
Fly Intel: Top five analyst downgrades
C Citi
$72.53 /

-0.39 (-0.53%)

04/13/21 Morgan Stanley
Citi price target raised to $89 from $81 at Morgan Stanley
04/09/21 Jefferies
Citi price target raised to $85 from $75 at Jefferies
04/07/21 Barclays
Citi price target raised to $84 from $77 at Barclays
04/05/21 Cowen
Risk to mortgage servicers rises as CFPB proposes foreclosure policy, says Cowen
BAC Bank of America
$38.75 /

-1.15 (-2.88%)

04/16/21 RBC Capital
Bank of America price target raised to $44 from $37 at RBC Capital
04/16/21 Baird
Bank of America price target raised to $42 from $38 at Baird
04/09/21 Jefferies
Bank of America price target raised to $41 from $33 at Jefferies
04/07/21 Barclays
Bank of America price target raised to $45 from $40 at Barclays
BLK BlackRock
$818.24 /

+15.52 (+1.93%)

04/16/21 Credit Suisse
BlackRock price target raised to $984 from $949 at Credit Suisse
04/16/21 Deutsche Bank
BlackRock price target raised to $912 from $847 at Deutsche Bank
04/16/21 Citi
BlackRock price target raised to $1,000 from $950 at Citi
04/16/21 Barclays
BlackRock price target raised to $925 from $850 at Barclays
UNH UnitedHealth
$390.14 /

+14.39 (+3.83%)

04/16/21 Morgan Stanley
UnitedHealth price target raised to $515 from $462 at Morgan Stanley
04/16/21 BMO Capital
UnitedHealth price target raised to $435 from $410 at BMO Capital
04/16/21 Oppenheimer
UnitedHealth price target raised to $440 from $375 at Oppenheimer
04/16/21 Deutsche Bank
UnitedHealth price target raised to $418 from $409 at Deutsche Bank
PEP PepsiCo
$142.20 /

+ (+0.00%)

04/16/21 Deutsche Bank
PepsiCo price target raised to $147 from $145 at Deutsche Bank
04/12/21 Wolfe Research
PepsiCo initiated with a Peer Perform at Wolfe Research
03/22/21
Fly Intel: Top five analyst upgrades
03/22/21 Barclays
PepsiCo upgraded to Overweight from Equal Weight at Barclays
DAL Delta Air Lines
$46.83 /

-1.32 (-2.74%)

04/15/21 Barclays
Delta Air Lines price target raised to $52 from $42 at Barclays
04/14/21 JPMorgan
Delta Air Lines price target raised to $63 from $49 at JPMorgan
04/09/21 Cowen
Delta Air Lines price target raised to $53 from $44 at Cowen
04/06/21 Morgan Stanley
Delta Air Lines price target raised to $72 from $55 at Morgan Stanley
TMO Thermo Fisher
$494.70 /

+16.97 (+3.55%)

04/16/21 Deutsche Bank
PPD downgraded to Hold from Buy at Deutsche Bank
04/16/21 William Blair
PPD downgraded to Market Perform from Outperform at William Blair
04/16/21 Evercore ISI
Thermo Fisher price target raised to $540 from $525 at Evercore ISI
04/16/21 KeyBanc
PPD downgraded to Sector Weight on takeover at KeyBanc
PPD PPD
$45.80 /

+3.3 (+7.76%)

04/16/21 Evercore ISI
PPD downgraded to In Line from Outperform at Evercore ISI
MRK Merck
$76.67 /

+0.27 (+0.35%)

04/16/21 William Blair
Atea selloff on Merck update unwarranted, says William Blair
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
04/08/21 Alliance Global Partners
Alliance Global Partners sees Fast Track for Immutep efti as meaningful positive
04/08/21 H.C. Wainwright
Alkermes collaboration not as big as investors wanted, says H.C. Wainwright
PFE Pfizer
$37.61 /

+0.45 (+1.21%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
DNZ D and Z Media Acquisition
$9.95 /

+0.045 (+0.45%)

ICE IntercontinentalExchange
$119.87 /

+1.695 (+1.43%)

04/06/21 Raymond James
IntercontinentalExchange price target raised to $136 at Raymond James
01/12/21 Barclays
IntercontinentalExchange price target raised to $134 from $125 at Barclays
01/07/21 Piper Sandler
IntercontinentalExchange price target raised to $127 from $117 at Piper Sandler
12/22/20 Compass Point
IntercontinentalExchange price target raised to $125 from $110 at Compass Point
WRI Weingarten Realty
$30.75 /

+3.375 (+12.33%)

04/16/21 Mizuho
Kimco Realty price target raised to $22 from $20 at Mizuho
04/16/21 Piper Sandler
Urstadt Biddle upgraded to Overweight from Neutral at Piper Sandler
04/15/21 Scotiabank
Weingarten Realty downgraded to Sector Perform from Outperform at Scotiabank
04/15/21 Truist
Kimco Realty, Weingarten Realty merger 'a win-win for both,' says Truist
KIM Kimco Realty
$19.92 /

+0.445 (+2.28%)

04/15/21 Deutsche Bank
Kimco Realty price target raised to $21 from $17 at Deutsche Bank
WIT Wipro
$6.55 /

+0.445 (+7.29%)

04/16/21 Citi
Wipro upgraded to Buy from Neutral at Citi
04/16/21 Nomura
Wipro upgraded to Neutral from Reduce at Nomura
04/16/21 Citi
Wipro upgraded to Buy from Neutral at Citi
03/05/21 ICICI Securities
Wipro downgraded to Sell from Reduce at ICICI Securities
SPCE Virgin Galactic
$23.05 /

-3.6 (-13.51%)

04/12/21 Bernstein
Virgin Galactic initiated with a Market Perform at Bernstein
03/16/21 Truist
Truist starts 'uniquely positioned' Virgin Galactic at Buy with $50 price target
03/16/21 Truist
Virgin Galactic initiated with a Buy at Truist
03/03/21 BofA
Virgin Galactic price target raised to $50 from $35 at BofA
QS QuantumScape
$35.86 /

-5.02 (-12.28%)

03/08/21 Cowen
Cowen bullish on battery technology, starts QuantumScape at Outperform
03/08/21 Cowen
QuantumScape initiated with an Outperform at Cowen
03/04/21 Baird
QuantumScape initiated with a Neutral at Baird
02/11/21 Morgan Stanley
QuantumScape initiated with an Overweight at Morgan Stanley
WRI Weingarten Realty
$30.75 /

+3.375 (+12.33%)

WIT Wipro
$6.55 /

+0.445 (+7.29%)

VMW VMware
$160.06 /

+4.57 (+2.94%)

UNH UnitedHealth
$390.14 /

+14.39 (+3.83%)

TMO Thermo Fisher
$494.70 /

+16.97 (+3.55%)

SPCE Virgin Galactic
$23.05 /

-3.6 (-13.51%)

PPD PPD
$45.80 /

+3.3 (+7.76%)

PFE Pfizer
$37.61 /

+0.45 (+1.21%)

PEP PepsiCo
$142.20 /

+ (+0.00%)

MRK Merck
$76.67 /

+0.27 (+0.35%)

KIM Kimco Realty
$19.92 /

+0.445 (+2.28%)

ICE IntercontinentalExchange
$119.87 /

+1.695 (+1.43%)

DELL Dell Technologies
$98.90 /

+6.2 (+6.69%)

DAL Delta Air Lines
$46.83 /

-1.32 (-2.74%)

C Citi
$72.53 /

-0.39 (-0.53%)

BLK BlackRock
$818.24 /

+15.52 (+1.93%)

BAC Bank of America
$38.75 /

-1.15 (-2.88%)

  • 25
    Mar
  • 05
    Nov
  • 17
    Sep
  • 10
    Sep
  • 06
    Aug
  • 03
    Jun
  • 20
    May
  • 13
    May
VMW VMware
$160.06 /

+4.57 (+2.94%)

UNH UnitedHealth
$390.14 /

+14.39 (+3.83%)

TMO Thermo Fisher
$494.70 /

+16.97 (+3.55%)

SPCE Virgin Galactic
$23.05 /

-3.6 (-13.51%)

QS QuantumScape
$35.86 /

-5.02 (-12.28%)

PFE Pfizer
$37.61 /

+0.45 (+1.21%)

PEP PepsiCo
$142.20 /

+ (+0.00%)

MRK Merck
$76.67 /

+0.27 (+0.35%)

ICE IntercontinentalExchange
$119.87 /

+1.695 (+1.43%)

DNZ D and Z Media Acquisition
$9.95 /

+0.045 (+0.45%)

DELL Dell Technologies
$98.90 /

+6.2 (+6.69%)

DAL Delta Air Lines
$46.83 /

-1.32 (-2.74%)

C Citi
$72.53 /

-0.39 (-0.53%)

BLK BlackRock
$818.24 /

+15.52 (+1.93%)

BAC Bank of America
$38.75 /

-1.15 (-2.88%)

VMW VMware
$160.06 /

+4.57 (+2.94%)

UNH UnitedHealth
$390.14 /

+14.39 (+3.83%)

TMO Thermo Fisher
$494.70 /

+16.97 (+3.55%)

SPCE Virgin Galactic
$23.05 /

-3.6 (-13.51%)

QS QuantumScape
$35.86 /

-5.02 (-12.28%)

PPD PPD
$45.80 /

+3.3 (+7.76%)

PFE Pfizer
$37.61 /

+0.45 (+1.21%)

PEP PepsiCo
$142.20 /

+ (+0.00%)

MRK Merck
$76.67 /

+0.27 (+0.35%)

ICE IntercontinentalExchange
$119.87 /

+1.695 (+1.43%)

DNZ D and Z Media Acquisition
$9.95 /

+0.045 (+0.45%)

DELL Dell Technologies
$98.90 /

+6.2 (+6.69%)

DAL Delta Air Lines
$46.83 /

-1.32 (-2.74%)

C Citi
$72.53 /

-0.39 (-0.53%)

BLK BlackRock
$818.24 /

+15.52 (+1.93%)

VMW VMware
$160.06 /

+4.57 (+2.94%)

UNH UnitedHealth
$390.14 /

+14.39 (+3.83%)

SPCE Virgin Galactic
$23.05 /

-3.6 (-13.51%)

QS QuantumScape
$35.86 /

-5.02 (-12.28%)

PFE Pfizer
$37.61 /

+0.45 (+1.21%)

PEP PepsiCo
$142.20 /

+ (+0.00%)

MRK Merck
$76.67 /

+0.27 (+0.35%)

KIM Kimco Realty
$19.92 /

+0.445 (+2.28%)

DELL Dell Technologies
$98.90 /

+6.2 (+6.69%)

DAL Delta Air Lines
$46.83 /

-1.32 (-2.74%)

C Citi
$72.53 /

-0.39 (-0.53%)

BAC Bank of America
$38.75 /

-1.15 (-2.88%)

Hot Stocks
Caesars expands partnership with National Football League » 16:26
04/15/21
04/15
16:26
04/15/21
16:26
CZR

Caesars

$93.18 /

-0.04 (-0.04%)

Caesars Entertainment…

Caesars Entertainment will become an Official Sports Betting Partner of the National Football League as part of an agreement that extends the groundbreaking partnership in which the company became the League's first-ever casino sponsor. The multi-year agreement, beginning with the upcoming 2021 NFL season, strengthens the partnership between two organizations, allowing Caesars to leverage NFL marks within the sports betting category and activate around retail and online sports betting, as well as engage fans with NFL-themed free-to-play games. As an Official Sports Betting Partner, Caesars will integrate relevant sports betting content directly into NFL Media properties, including NFL.com and the NFL App. Caesars will partner with the League to create content and opportunities for engagement for both its legal online sports betting operations and its expansive retail sportsbook locations across the country. Continuing as the Official Casino Sponsor of the NFL, Caesars retains its exclusive casino rights to use NFL trademarks in its marketing and provide unique experiences for NFL fans using its more than 50 casino properties, celebrity chefs, premier music artists, and a wide range of entertainment elements onsite. As the Official Casino Sponsor, Caesars will create tentpole activations at key NFL events, including the 2022 Pro Bowl and 2022 NFL Draft in Las Vegas and Super Bowl LIX in 2025 in New Orleans. The extended agreement also encompasses Caesars online iGaming applications where the Company will engage NFL fans beyond the traditional football season.

ShowHide Related Items >><<
CZR Caesars
$93.18 /

-0.04 (-0.04%)

CZR Caesars
$93.18 /

-0.04 (-0.04%)

04/08/21 KeyBanc
Caesars price target raised to $110 from $102 at KeyBanc
04/07/21 Truist
Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud'
04/06/21 Credit Suisse
Reports, contacts point to sports betting momentum in NY, Credit Suisse says
04/05/21
Fly Intel: Top five analyst upgrades
CZR Caesars
$93.18 /

-0.04 (-0.04%)

  • 29
    Sep
CZR Caesars
$93.18 /

-0.04 (-0.04%)

CZR Caesars
$93.18 /

-0.04 (-0.04%)

CZR Caesars
$93.18 /

-0.04 (-0.04%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.